Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories

Series B

Corporates align with Purigen in series B round
Roche participated in the Agilent Technologies-led round, which will fund the launch of Stanford spinout Purigen's isotachophoresis-based DNA and RNA sample preparation platform.
Audio Analytic passes $12m audition
Cambridge Innovation Capital backed sound recognition technology developer Audio Analytic's $12m series B round, having previously also supported a $5.5m series A in 2017.
Cardinal Analytx ticks off $23m series B
GuideWell Mutual, Blue Shield California and existing backer Premera Blue Cross all invested in the healthcare prediction platform developer based on Stanford research.
AlloVir secures $120m funding allocation
The T-Cell therapy developer, based on research at Baylor College of Medicine, has received funding in a Gilead Sciences-backed series B round led by Fidelity Management and Research.
Pixie Dust cleans up with series B funding
Pixie Dust Technologies, which promotes university-derived technologies from Japan, has received $34.7m in a round that included KDDI, Kansai Electric Power, NEC, Toppan, Dai-ichi Life and Dentsu.
CVC Investment in a Spinout of the Year: Ribon Therapeutics
Winner of the CVC Investment in a Spinout of the Year: Ribon Therapeutics - Novartis Venture Fund, Johnson & Johnson Innovation–JJDC, Takeda Ventures, Celgene
Algorithmia computes $25m series B
Osage University Partners, Gradient Ventures and Rakuten Ventures featured in machine learning software developer Algorithmia's latest round, which brought its total to $37.9m.
Understory weathers storm for $5.3m
Warf-backed 4490 Ventures has returned to supply funding to weather analytics service Understory in support of the latter’s international expansion and recruitment strategy.

Other News

Kiyatec knocks for $3m
Based on Clemson University research, 3D cancer cell modelling spinout Kiyatec has increased its total financing to $14.9m with the help of clinical lab operator LabCorp and VC firm VentureSouth.
Congenica finds more series B congeniality
The CIC-backed clinical genomics platform operator took its series B round to $30.1m following a $17.1m extension that will fund the development of automation and statistical analysis functionality.
Satsuma squeezes $62m out of series B
Osage University Partners has participated in a $62m series B round for Satsuma Pharmaceuticals, which also featured Shin Nippon Biomedical Laboratories.
Arrakis arranges $75m series B
Osage University has returned for a $75m series B round raised by Arrakis Therapeutics, which has licensed technology from University of Pennsylvania.
Cytora assesses $32.6m series B
Cambridge Innovation Capital and Parkwalk Advisors have both returned to back a $32.6m series B round for Cytora, an insurance technology spinout of Cambridge.
Cardinal Analytx processes series B
Stanford spinout Cardinal Analytx has raised $20.6m out of a targeted $29.3m, adding to a $6.1m series A round backed by Stanford-StartX Fund in 2017.

Editor's Picks

Big deal: Ribon ties together $65m series B
Ribon Therapeutics has emerged out of stealth after three years of developing a lead asset targeting cancer based on research at MIT, UT Southwestern and Harvard Medical School.
Canvas paints $9m picture
Canvas Network, an online education platform developed by learning management software (LMS) provider Instructure which received $9.1m investment for the platform, has begun offering free and open online courses.
WRF finds its Resolve
In May 2010, Resolve raised $2m in the initial close of its A round before bringing in a corporate venturing unit later.
Imperial helps PsiOxus raise $34m
UK-listed investment fund Imperial Innovations joins GlaxoSmithKline's SR One, fund manager Invesco Perpetual and Lundbeckfond Ventures, backing the d cancer treatment company.
test reg